The buyside build-up has come to nothing:I would suggest that a...

The buyside build-up has come to nothing:I would suggest that a certain expectation has proved to be false;perhaps underwhelming sales figures,or [the highly likely] delay of the listing,or something else.Perhaps an announcement is coming.Anything really disappointing should drive the SP below one cent.
Of course,if the company informed the investor about current progress,one wouldn't have to speculate!All we know is that no evidence that the product is selling well.Infact,common sense suggests that insiders would be buying at these levels if good news was forecoming.
None of this should be unexpected when investing in a bio-tech in an insipid market.Establishing these products in the marketplace is proving to more difficult than most of us expected.



Good Luck all holders